Bb Biotech as of Sept. 30, 2013
Portfolio Holdings for Bb Biotech
Bb Biotech holds 24 positions in its portfolio as reported in the September 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Celgene Corporation | 16.8 | $308M | 2.0M | 154.14 | |
| ISIS Pharmaceuticals | 14.7 | $270M | 7.2M | 37.54 | |
| Gilead Sciences (GILD) | 12.4 | $228M | 3.6M | 62.87 | |
| Incyte Corporation (INCY) | 9.9 | $182M | 4.8M | 38.15 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 5.8 | $107M | 1.4M | 75.82 | |
| Alexion Pharmaceuticals | 4.8 | $88M | 757k | 116.16 | |
| Medivation | 4.7 | $87M | 1.4M | 59.94 | |
| Ariad Pharmaceuticals | 3.7 | $68M | 3.7M | 18.40 | |
| Halozyme Therapeutics (HALO) | 3.3 | $61M | 5.5M | 11.04 | |
| ImmunoGen | 3.0 | $56M | 3.3M | 17.02 | |
| Pharmacyclics | 3.0 | $55M | 399k | 138.26 | |
| Synageva Biopharma | 2.5 | $45M | 715k | 63.39 | |
| Onyx Pharmaceuticals | 2.3 | $42M | 340k | 124.70 | |
| Theravance | 2.0 | $36M | 888k | 40.87 | |
| Regeneron Pharmaceuticals (REGN) | 1.7 | $32M | 102k | 312.87 | |
| Endocyte | 1.6 | $30M | 2.3M | 13.33 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $30M | 471k | 64.01 | |
| Clovis Oncology | 1.3 | $23M | 382k | 60.80 | |
| Infinity Pharmaceuticals (INFIQ) | 1.2 | $23M | 1.3M | 17.43 | |
| Neurocrine Biosciences (NBIX) | 1.2 | $22M | 2.0M | 11.32 | |
| Optimer Pharmaceuticals | 1.0 | $18M | 1.4M | 12.59 | |
| Tesaro | 0.8 | $15M | 373k | 38.74 | |
| Idenix Pharmaceuticals | 0.3 | $6.5M | 1.3M | 5.19 | |
| Achillion Pharmaceuticals | 0.3 | $5.4M | 1.8M | 3.02 |
